Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Osteoprotegerin/sRANKL Ratio and Bone Mineral Density in Patients With Primary Hyperparathyroidism Treated With Parathyroidectomy or Alendronate

NCT01889134 is registered in ClinicalTrials.gov with Wroclaw Medical University as lead sponsor.

NCT NCT01889134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01889134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Osteoprotegerin/sRANKL Ratio and Bone Mineral Density in Patients With Primary Hyperparathyroidism Treated With Parathyroidectomy or Alendronate
Lead sponsor
Wroclaw Medical University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2009
Completion date
October 31, 2012
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary hyperparathyroidism